Thomas E Jr Polen, the Chairman of $BDX, sold 2,764 shares of the company on 06-01-2026 for an estimated $404,511. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.4% of their shares of this class of stock. Following this trade, they now own 110,163 shares of this class of $BDX stock.
$BDX Insider Trading Activity
$BDX insiders have traded $BDX stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $BDX stock by insiders over the last 6 months:
- MICHAEL DAVID GARRISON (EVP & Pres Med.Essntl&BioPharm) has made 0 purchases and 3 sales selling 2,239 shares for an estimated $457,308.
- THOMAS E JR POLEN (Chairman, CEO and President) sold 2,764 shares for an estimated $404,511
- BERTRAM L SCOTT sold 953 shares for an estimated $174,027
- MICHAEL FELD (EVP, Chief Revenue Officer) has made 0 purchases and 6 sales selling 448 shares for an estimated $77,409.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$BDX Hedge Fund Activity
We have seen 691 institutional investors add shares of $BDX stock to their portfolio, and 815 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AUTO-OWNERS INSURANCE CO removed 40,501,260 shares (-99.5%) from their portfolio in Q1 2026, for an estimated $6,303,616,106
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 6,005,889 shares (-37.0%) from their portfolio in Q4 2025, for an estimated $1,165,562,878
- VANGUARD GROUP INC added 4,223,149 shares (+13.0%) to their portfolio in Q4 2025, for an estimated $819,586,526
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO removed 4,140,223 shares (-99.6%) from their portfolio in Q1 2026, for an estimated $644,384,307
- GENERATION INVESTMENT MANAGEMENT LLP removed 1,984,672 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $385,165,295
- JPMORGAN CHASE & CO removed 1,794,165 shares (-33.9%) from their portfolio in Q4 2025, for an estimated $348,193,601
- BLACKROCK, INC. removed 1,495,294 shares (-5.4%) from their portfolio in Q1 2026, for an estimated $232,727,558
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$BDX Revenue
$BDX had revenues of $4.7B in Q2 2026. This is a decrease of -10.58% from the same period in the prior year.
You can track BDX financials on Quiver Quantitative's BDX stock page.
You can access data on BDX stock through the Quiver Quantitative API.
$BDX Congressional Stock Trading
Members of Congress have traded $BDX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $BDX stock by members of Congress over the last 6 months:
- REPRESENTATIVE KEVIN HERN sold up to $50,000 on 03/17.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$BDX Price Targets
Multiple analysts have issued price targets for $BDX recently. We have seen 12 analysts offer price targets for $BDX in the last 6 months, with a median target of $177.5.
Here are some recent targets:
- Matt Miksic from Barclays set a target price of $204.0 on 05/11/2026
- Lawrence Biegelsen from Wells Fargo set a target price of $161.0 on 05/08/2026
- Joshua Jennings from TD Cowen set a target price of $163.0 on 05/04/2026
- Jason Bednar from Piper Sandler set a target price of $159.0 on 04/17/2026
- David Roman from Goldman Sachs set a target price of $167.0 on 04/10/2026
- David Toung from Argus Research set a target price of $180.0 on 03/23/2026
- Joanna Wiensch from Citigroup set a target price of $198.0 on 02/11/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
